206 related articles for article (PubMed ID: 25047051)
41. Urodynamic effectiveness of a beta-3 adrenoreceptor agonist (vibegron) for a pediatric patient with anticholinergic-resistant neurogenic detrusor overactivity: a case report.
Kato T; Mizuno K; Nishio H; Yasui T; Hayashi Y
J Med Case Rep; 2021 Feb; 15(1):86. PubMed ID: 33602290
[TBL] [Abstract][Full Text] [Related]
42. Anticholinergic burden and comorbidities in patients attending treatment with trospium chloride for overactive bladder in a real-life setting: results of a prospective non-interventional study.
Ivchenko A; Bödeker RH; Neumeister C; Wiedemann A
BMC Urol; 2018 Sep; 18(1):80. PubMed ID: 30217174
[TBL] [Abstract][Full Text] [Related]
43. Neurogenic bladder in patients with traumatic spinal cord injury: treatment and follow-up.
; Yıldız N; Akkoç Y; Erhan B; Gündüz B; Yılmaz B; Alaca R; Gök H; Köklü K; Ersöz M; Cınar E; Karapolat H; Catalbaş N; Bardak AN; Turna I; Demir Y; Güneş S; Alemdaroğlu E; Tunç H
Spinal Cord; 2014 Jun; 52(6):462-7. PubMed ID: 24732167
[TBL] [Abstract][Full Text] [Related]
44. Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injury.
O'Leary M; Erickson JR; Smith CP; McDermott C; Horton J; Chancellor MB
J Spinal Cord Med; 2003; 26(2):159-62. PubMed ID: 12828295
[TBL] [Abstract][Full Text] [Related]
45. Multi-center randomized controlled trial of cognitive treatment, placebo, oxybutynin, bladder training, and pelvic floor training in children with functional urinary incontinence.
van Gool JD; de Jong TP; Winkler-Seinstra P; Tamminen-Möbius T; Lax H; Hirche H; Nijman RJ; Hjälmås K; Jodal U; Bachmann H; Hoebeke P; Walle JV; Misselwitz J; John U; Bael A;
Neurourol Urodyn; 2014 Jun; 33(5):482-7. PubMed ID: 23775924
[TBL] [Abstract][Full Text] [Related]
46. Botulinum toxin-type A in the treatment of drug-resistant neurogenic detrusor overactivity secondary to traumatic spinal cord injury.
Patki PS; Hamid R; Arumugam K; Shah PJ; Craggs M
BJU Int; 2006 Jul; 98(1):77-82. PubMed ID: 16831148
[TBL] [Abstract][Full Text] [Related]
47. Botulinum toxin type A for neurogenic detrusor overactivity due to spinal cord lesions in children: a retrospective study of seven cases.
Do Ngoc Thanh C; Audry G; Forin V
J Pediatr Urol; 2009 Dec; 5(6):430-6. PubMed ID: 19577520
[TBL] [Abstract][Full Text] [Related]
48. Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity.
Ginsberg D; Gousse A; Keppenne V; Sievert KD; Thompson C; Lam W; Brin MF; Jenkins B; Haag-Molkenteller C
J Urol; 2012 Jun; 187(6):2131-9. PubMed ID: 22503020
[TBL] [Abstract][Full Text] [Related]
49. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability.
Halaska M; Ralph G; Wiedemann A; Primus G; Ballering-Brühl B; Höfner K; Jonas U
World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500
[TBL] [Abstract][Full Text] [Related]
50. Efficacy, safety, and tolerability of intravesically administered 0.1% oxybutynin hydrochloride solution in adult patients with neurogenic bladder: A randomized, prospective, controlled multi-center trial.
Schröder A; Albrecht U; Schnitker J; Reitz A; Stein R
Neurourol Urodyn; 2016 Jun; 35(5):582-8. PubMed ID: 25754454
[TBL] [Abstract][Full Text] [Related]
51. Efficacy, tolerability and safety of propiverine hydrochloride in comparison to oxybutynin in children with urge incontinence due to overactive bladder: Results of a multicentre observational cohort study.
Alloussi S; Mürtz G; Braun R; Gerhardt U; Heinrich M; Hellmis E; Horn W; Marschall-Kehrel D; Niklas K; Raabe M; Rössler T; Seibt B; Siemer S; Schultz-Lampel D; Walter H; Wiedeking B; Alloussi S; Bock P; Strugala G; Madersbacher H
BJU Int; 2010 Aug; 106(4):550-6. PubMed ID: 20002668
[TBL] [Abstract][Full Text] [Related]
52. Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study.
Gacci M; Del Popolo G; Macchiarella A; Celso M; Vittori G; Lapini A; Serni S; Sandner P; Maggi M; Carini M
J Urol; 2007 Nov; 178(5):2040-3; discussion 2044. PubMed ID: 17869296
[TBL] [Abstract][Full Text] [Related]
53. Combined low-dose antimuscarinics for refractory detrusor overactivity in children.
Fahmy A; Youssif M; Rhashad H; Mokhless I; Mahfouz W
J Pediatr Urol; 2016 Aug; 12(4):219.e1-5. PubMed ID: 27282551
[TBL] [Abstract][Full Text] [Related]
54. Beneficial carry-over effects of chronic at-home genital nerve stimulation on incontinence in individuals with spinal cord injury: A pragmatic trial.
Yeh SD; Khasanah N; Gustafson KJ; Sun C; Tsai ML; Lin BS; Wu CW; Peng CW
Ann Phys Rehabil Med; 2024 Mar; 67(2):101799. PubMed ID: 38128350
[TBL] [Abstract][Full Text] [Related]
55. The role of the prostacyclin receptor antagonist RO3244019 in treating neurogenic detrusor overactivity after spinal cord injury in rats.
Khera M; Boone TB; Salas N; Jett MF; Somogyi GT
BJU Int; 2007 Feb; 99(2):442-6. PubMed ID: 17313428
[TBL] [Abstract][Full Text] [Related]
56. Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis.
Madhuvrata P; Singh M; Hasafa Z; Abdel-Fattah M
Eur Urol; 2012 Nov; 62(5):816-30. PubMed ID: 22397851
[TBL] [Abstract][Full Text] [Related]
57. Urodynamic effects of propiverine hydrochloride in children with neurogenic detrusor overactivity: a prospective analysis.
Schulte-Baukloh H; Mürtz G; Henne T; Michael T; Miller K; Knispel HH
BJU Int; 2006 Feb; 97(2):355-8. PubMed ID: 16430646
[TBL] [Abstract][Full Text] [Related]
58. [Percutaneous radiofrequency sacral rhizotomy in the treatment of neurogenic detrusor overactivity in spinal cord injured patients].
Ferreira RS; Levi d'Ancona CA; Dantas-Filho VP; Rodrigues Netto N; Miyaoka R
Actas Urol Esp; 2011 Jun; 35(6):325-30. PubMed ID: 21477886
[TBL] [Abstract][Full Text] [Related]
59. Effect of trospium chloride on urodynamic parameters in patients with detrusor hyperreflexia due to spinal cord injuries. A multicentre placebo-controlled double-blind trial.
Stöhrer M; Bauer P; Giannetti BM; Richter R; Burgdörfer H; Mürtz G
Urol Int; 1991; 47(3):138-43. PubMed ID: 1771701
[TBL] [Abstract][Full Text] [Related]
60. Trospium chloride versus oxybutynin: a randomized, double-blind, multicentre trial in the treatment of detrusor hyper-reflexia.
Madersbacher H; Stöhrer M; Richter R; Burgdörfer H; Hachen HJ; Mürtz G
Br J Urol; 1995 Apr; 75(4):452-6. PubMed ID: 7788255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
